Skip to main content
OpenTrials
Completed

NCT Number: NCT01929252

Postoperative Analgesic Effect Of Dexmedetomidine Administration in Wound Infiltration for Total Abdominal Hysterectomy

The aim of this study was to investigate the analgesic efficacy of dexmedetomidine administration in wound infiltration for total abdominal hysterectomy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 4

Primary location

Erciyes university hospital

Kayseri, 38039, Turkey (Türkiye)

About this study

Abdominal hysterectomy is associated with moderate to severe postoperative pain, effective analgesia after hysterectomy essential and several techniques are used such as administration of opioids, nonsteroidal anti-inflammatory drugs and wound infiltration of local anaesthetics. Different local anaesthetics can be used for the wound infiltration techniques.Ifiltration of the surgical wound with bupivacaine following outpatient provides pain relief in the postoperative period , allows the early discharge from the outpatient surgical units.There has been increased interest in administration of analgesic prior to surgical injury. Dexmedetomidine is a highly selective alpha-2 adrenergic agonist with sedative , anxiolytic, analgesic, sympatholytic and antihypertensive effects.Dexmedetomidine has been used intravenously before initiation of anaesthesia and it has shown to provide some analgesic effect after surgery but there were some adverse hemodynamic effects. Surgical wound administration of dexmedetomidine may be useful to avoid the adverse haemodynamic effects of intravenous administration while still providing the postoperative analgesia.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18-65 yo female
  • scheduled for elective hysterectomy
  • no known allergies to drugs
  • ASA 1=2 patients

Exclusion criteria

  • history of diabetes
  • history of chronic pain treatment
  • pregnancy

Treatment and study plan

Dexmedetomidine

Drug

2mcg.kg-1 dexmedetomidine wound infiltration

Other names: precedex

Levobupivacaine

Drug

0.25% levobupivacaine (40ml) wound infiltration

Other names: chirocaine

Primary outcomes

  1. Analgesic Consumption

    Time frame: 1 day after surgery

    Pethidine consumption (patient controlled analgesia procedure) was recorded

Secondary outcomes

  1. Visual Analog Scale

    Time frame: 1 day after surgery

    Visual analog scale on rest and movement was recorded.

  2. Haemodynamic Changes

    Time frame: During the surgery

    Arterial blood pressure, heart rate, peripheral oxygen saturation

Sponsors and collaborators

Lead sponsor

TC Erciyes University

Other

Registry information

Official study title

Phase 4 Study of Postoperative Analgesic Effect Of Dexmedetomidine Administration in Wound Infiltration For Total Abdominal Hysterectomy

Important dates

Study start
2011
Primary completion
2011
Study completion
2012
First posted
Aug 27, 2013
Registry last updated
Aug 27, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.